These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11487337)

  • 1. Chelators for radioimmunotherapy: I. NMR and ab initio calculation studies on 1,4,7,10-tetra(carboxyethyl)-1,4,7,10-tetraazacyclododecane (DO4Pr) and 1,4,7-tris(carboxymethyl)-10-(carboxyethyl)-1,4,7,10-tetraazacyclododecane (DO3A1Pr).
    Keire DA; Jang YH; Li L; Dasgupta S; Goddard WA; Shively JE
    Inorg Chem; 2001 Aug; 40(17):4310-8. PubMed ID: 11487337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR studies of the metal-loading kinetics and acid-base chemistry of DOTA and butylamide-DOTA.
    Keire DA; Kobayashi M
    Bioconjug Chem; 1999; 10(3):454-63. PubMed ID: 10346878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of novel macrocyclic ligands with pendent donor groups as potential yttrium chelators for radioimmunotherapy with improved complex formation kinetics.
    Chong HS; Garmestani K; Ma D; Milenic DE; Overstreet T; Brechbiel MW
    J Med Chem; 2002 Aug; 45(16):3458-64. PubMed ID: 12139456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yttrium-90 chelation properties of tetraazatetraacetic acid macrocycles, diethylenetriaminepentaacetic acid analogues, and a novel terpyridine acyclic chelator.
    Stimmel JB; Stockstill ME; Kull FC
    Bioconjug Chem; 1995; 6(2):219-25. PubMed ID: 7599265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of yttrium and indium complexes of DOTA-BA and DOTA-MBA: models for (90)Y- and (111)In-labeled DOTA-biomolecule conjugates.
    Liu S; Pietryka J; Ellars CE; Edwards DS
    Bioconjug Chem; 2002; 13(4):902-13. PubMed ID: 12121149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid for radiolabeling proteins.
    Chappell LL; Ma D; Milenic DE; Garmestani K; Venditto V; Beitzel MP; Brechbiel MW
    Nucl Med Biol; 2003 Aug; 30(6):581-95. PubMed ID: 12900284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.
    Boswell CA; Sun X; Niu W; Weisman GR; Wong EH; Rheingold AL; Anderson CJ
    J Med Chem; 2004 Mar; 47(6):1465-74. PubMed ID: 14998334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 90Y-DOTA-hLL2: an agent for radioimmunotherapy of non-Hodgkin's lymphoma.
    Griffiths GL; Govindan SV; Sharkey RM; Fisher DR; Goldenberg DM
    J Nucl Med; 2003 Jan; 44(1):77-84. PubMed ID: 12515879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation kinetics and stability studies on the lanthanide complexes of 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid by capillary electrophoresis.
    Zhu X; Lever SZ
    Electrophoresis; 2002 May; 23(9):1348-56. PubMed ID: 12007137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new biotin derivative-DOTA conjugate as a candidate for pretargeted diagnosis and therapy of tumors.
    Sabatino G; Chinol M; Paganelli G; Papi S; Chelli M; Leone G; Papini AM; De Luca A; Ginanneschi M
    J Med Chem; 2003 Jul; 46(14):3170-3. PubMed ID: 12825956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized conditions for chelation of yttrium-90-DOTA immunoconjugates.
    Kukis DL; DeNardo SJ; DeNardo GL; O'Donnell RT; Meares CF
    J Nucl Med; 1998 Dec; 39(12):2105-10. PubMed ID: 9867151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of DOTA-Metal Chelation Effects on the Chemical Shift of (129) Xe.
    Jeong K; Slack CC; Vassiliou CC; Dao P; Gomes MD; Kennedy DJ; Truxal AE; Sperling LJ; Francis MB; Wemmer DE; Pines A
    Chemphyschem; 2015 Dec; 16(17):3573-7. PubMed ID: 26376768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of a novel 'smart' bifunctional chelating agent 1-(2-[beta,D-galactopyranosyloxy]ethyl)-7-(1-carboxy-3-[4-aminophenyl]propyl)-4,10-bis(carboxymethyl)-1,4,7,10-tetraazacyclododecane (Gal-PA-DO3A-NH2) and its Gd(III) complex.
    Wardle NJ; Herlihy AH; So PW; Bell JD; Bligh SW
    Bioorg Med Chem; 2007 Jul; 15(14):4714-21. PubMed ID: 17512738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling of bifunctional chelate peptide conjugates. 1. Copper and indium parameters for the AMBER force field.
    Reichert DE; Norrby PO; Welch MJ
    Inorg Chem; 2001 Sep; 40(20):5223-30. PubMed ID: 11559086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of novel ligands for radioimmunotherapy.
    Chong HS; Milenic DE; Garmestani K; Brady ED; Arora H; Pfiester C; Brechbiel MW
    Nucl Med Biol; 2006 May; 33(4):459-67. PubMed ID: 16720237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A benzimidazole functionalised DO3A chelator showing pH switchable coordination modes with lanthanide ions.
    Fisher CM; Fuller E; Burke BP; Mogilireddy V; Pope SJ; Sparke AE; Déchamps-Olivier I; Cadiou C; Chuburu F; Faulkner S; Archibald SJ
    Dalton Trans; 2014 Jul; 43(25):9567-78. PubMed ID: 24828602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relaxometric and solution NMR structural studies on ditopic lanthanide(III) complexes of a phosphinate analogue of DOTA with a fast rate of water exchange.
    Rudovský J; Botta M; Hermann P; Koridze A; Aime S
    Dalton Trans; 2006 May; (19):2323-33. PubMed ID: 16688320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermodynamic and kinetic study of scandium(III) complexes of DTPA and DOTA: a step toward scandium radiopharmaceuticals.
    Pniok M; Kubíček V; Havlíčková J; Kotek J; Sabatie-Gogová A; Plutnar J; Huclier-Markai S; Hermann P
    Chemistry; 2014 Jun; 20(26):7944-55. PubMed ID: 24838869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and stability of the [
    Roy T; Pogorilyy E; Kumarananthan CP; Kvitastein UA; Foscato M; Törnroos KW; Adamsen TCH; Le Roux E
    Chem Commun (Camb); 2024 Jul; 60(56):7148-7151. PubMed ID: 38860653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging chelators for nuclear imaging.
    Sneddon D; Cornelissen B
    Curr Opin Chem Biol; 2021 Aug; 63():152-162. PubMed ID: 34051509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.